GlobalData on MSN

Tandem secures FDA approval for Control-IQ+ use in pregnancy

The approval is based on findings from the CIRCUIT trial published in JAMA in October 2025.

Tandem Diabetes Care’s Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes

FDA clears Tandem Diabetes Care's Control-IQ+ automated insulin delivery technology for use in pregnancy for people with type ...
Healio

FDA clears first automated insulin delivery system for type 1 diabetes during pregnancy

The FDA cleared an automated insulin delivery system for use by pregnant women with type 1 diabetes, according to an industry ...
Nasdaq

Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that its next-generation automated insulin delivery ...
FierceBiotech

Tandem Diabetes Care cruises to FDA OK of automated insulin delivery for toddlers

Helping toddlers manage their Type 1 diabetes—typically a difficult task, due to their constant growth and development, not to mention fussiness—may now be a bit easier. The FDA has expanded its ...
FierceBiotech

Tandem auto-bolusing artificial pancreas has greatest impact on highest glucose levels: study

Tandem Diabetes Care has already proven that its closed-loop system for automated insulin delivery can improve the amount of time spent in range for people of all ages with Type 1 diabetes, but a new ...